Potential benefit from implantable cardioverter-defibrillator therapy in patients with and without heart failure

Circulation

Volumn 98, Issue 16, 1998, Pages 1636-1643

  Böcker, Dirk ^a   Bänsch, Dietmar ^a   Heinecke, Achim ^a   Weber, Max ^a   Brunn, Jürgen ^a   Hammel, Dieter ^a   Borggrefe, Martin ^a   Breithardt, Günter ^a   Block, Michael ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Cardioversion; Defibrillation; Heart failure; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVERSION; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DEVICE; ELECTROCARDIOGRAM; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

EID: 0032552905     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.16.1636     Document Type: Article

References (17)

1. Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, Langer A, Heilman MS, Kolenik S, Fischell RE, Weisfeldt M. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 1980;303:322-324.
2. Mirowski M, Reid PR, Winkle RA, Mower MM, Watkins L, Stinson EB, Griffith LSC, Kallman CH, Weisfeldt ML. Mortality in patients with implanted automatic defibrillators. Ann Intern Med. 1983;98:585-588.
3. The PCD Investigator Group. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. J Am Coll Cardiol. 1994;23:1521-1530.
4. Fogoros RN, Elson JJ, Bonnet CA, Fiedler SB, Burkholder JA. Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease. J Am Coll Cardiol. 1990;16:381-386.
5. Böcker D, Block M, Isbruch F, Wietholt D, Hammel D, Borggrefe M, Breithardt G. Do patients with an implantable defibrillator live longer? J Am Coll Cardiol. 1993;21:1638-1644.
6. Saksena S, Madan N, Lewis C. Implanted cardioverter-defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias. Prog Cardiovasc Dis. 1996;38:445-454.
7. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
8. Bigger JT, for the Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med. 1997;337:1569-1575.
9. Kuck KH. Prospective studies assessing prophylactic therapy in high risk patients: the German Dilated CardioMyopathy Study (GDCMS): study design. Pacing Clin Electrophysiol. 1992;15:697-700.
10. Böcker D, Block M, Isbruch F, Wietholt D, Hammel D, Scheid HH, Borggrefe M, Breithardt G. Comparison of frequency of aggravation of ventricular tachyarrhythmias after implantation of automatic defibrillators using epicardial versus nonthoracotomy lead systems. Am J Cardiol. 1993;71:1064-1068.
11. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: John Wiley & Sons; 1980.
12. Sweeney MO, Ruskin JN, Garan H, McGovern BA, Guy ML, Torchiana DF, Vlahakes GJ, Newell JB, Semigran MJ, Dec GW. Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation. 1995;92: 3273-3281.
13. Kim SG, Fisher JD, Choue CW, Gross J, Roth J, Ferrick KJ, Brodman R, Furman S. Influence of left ventricular function on outcome of patients treated with implantable defibrillators. Circulation. 1992;85: 1304-1310.
14. Mehta D, Saksena S, Krol RB, John T, Saxena A, Raju R, Kaushik R, Karanam R. Device use patterns and clinical outcome of implantable cardioverter defibrillator patients with moderate and severe impairment of left ventricular function. Pacing Clin Electrophysiol. 1993;16:179-185.
15. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M, for the MADIT Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933-1940.
16. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576-1583.
17. Nisam S, Breithardt G. Mortality trials with implantable defibrillators. Am J Cardiol. 1997;79:468-471.